Free Trial

Oncolytics Biotech (ONCY) News Today

Oncolytics Biotech logo
$0.60 -0.01 (-2.31%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$0.60 0.00 (-0.50%)
As of 03/28/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Oncolytics Biotech Inc. stock logo
What is HC Wainwright's Estimate for ONCY FY2027 Earnings?
Oncolytics Biotech Inc. (NASDAQ:ONCY - Free Report) - HC Wainwright upped their FY2027 earnings per share (EPS) estimates for Oncolytics Biotech in a research report issued on Monday, March 10th. HC Wainwright analyst P. Trucchio now expects that the company will earn ($0.08) per share for the ye
Oncolytics Biotech Inc. stock logo
Leede Financial Has Positive Outlook of ONCY FY2025 Earnings
Oncolytics Biotech Inc. (NASDAQ:ONCY - Free Report) - Investment analysts at Leede Financial raised their FY2025 earnings per share (EPS) estimates for Oncolytics Biotech in a research note issued to investors on Monday, March 10th. Leede Financial analyst D. Loe now forecasts that the company wi
Oncolytics Biotech Inc. stock logo
HC Wainwright Cuts Earnings Estimates for Oncolytics Biotech
Oncolytics Biotech Inc. (NASDAQ:ONCY - Free Report) - Investment analysts at HC Wainwright dropped their FY2029 earnings per share (EPS) estimates for Oncolytics Biotech in a research note issued to investors on Monday, March 10th. HC Wainwright analyst P. Trucchio now forecasts that the company
Oncolytics Biotech Inc. stock logo
Maxim Group Issues Pessimistic Forecast for Oncolytics Biotech (NASDAQ:ONCY) Stock Price
Maxim Group lowered their price objective on Oncolytics Biotech from $5.00 to $3.00 and set a "buy" rating for the company in a report on Monday.
Oncolytics Biotech Inc. stock logo
Oncolytics Biotech's (ONCY) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated a "buy" rating and set a $5.00 price target on shares of Oncolytics Biotech in a research report on Monday.
Oncolytics Biotech Inc. stock logo
Royal Bank of Canada Cuts Oncolytics Biotech (NASDAQ:ONCY) Price Target to $5.00
Royal Bank of Canada lowered their price target on shares of Oncolytics Biotech from $6.00 to $5.00 and set an "outperform" rating for the company in a research report on Monday.
Oncolytics price target lowered to $3 from $5 at Maxim
Oncolytics Biotech Inc. stock logo
Oncolytics Biotech (NASDAQ:ONCY) Announces Quarterly Earnings Results
Oncolytics Biotech (NASDAQ:ONCY - Get Free Report) announced its quarterly earnings results on Friday. The company reported ($0.07) EPS for the quarter, beating analysts' consensus estimates of ($0.08) by $0.01.
Oncolytics Biotech Inc. stock logo
Oncolytics Biotech Inc. (NASDAQ:ONCY) Short Interest Down 14.1% in February
Oncolytics Biotech Inc. (NASDAQ:ONCY - Get Free Report) was the target of a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 3,050,000 shares, a decrease of 14.1% from the January 31st total of 3,550,000 shares. Based on an average daily volume of 1,150,000 shares, the short-interest ratio is presently 2.7 days.
Oncolytics Biotech Inc. stock logo
Oncolytics Biotech (ONCY) to Release Quarterly Earnings on Friday
Oncolytics Biotech (NASDAQ:ONCY) will be releasing earnings before the market opens on Friday, March 7, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=669693)
Oncolytics Biotech advances pancreatic, anal cancer trials
Oncolytics making progress in 2025 with regulatory, clinical advancements
Oncolytics Biotech Inc. stock logo
Short Interest in Oncolytics Biotech Inc. (NASDAQ:ONCY) Rises By 35.0%
Oncolytics Biotech Inc. (NASDAQ:ONCY - Get Free Report) saw a large growth in short interest in January. As of January 31st, there was short interest totalling 3,550,000 shares, a growth of 35.0% from the January 15th total of 2,630,000 shares. Based on an average daily volume of 1,170,000 shares, the days-to-cover ratio is currently 3.0 days.
Oncolytics receives noncompliance notification from Nasdaq
Oncolytics Biotech Inc. stock logo
What is HC Wainwright's Estimate for ONCY FY2024 Earnings?
Oncolytics Biotech Inc. (NASDAQ:ONCY - Free Report) - Analysts at HC Wainwright upped their FY2024 EPS estimates for Oncolytics Biotech in a research report issued on Monday, February 3rd. HC Wainwright analyst P. Trucchio now forecasts that the company will earn ($0.28) per share for the year, u
Oncolytics Biotech Inc. stock logo
Brokers Issue Forecasts for ONCY FY2029 Earnings
Oncolytics Biotech Inc. (NASDAQ:ONCY - Free Report) - Stock analysts at HC Wainwright issued their FY2029 earnings estimates for Oncolytics Biotech in a research note issued on Monday, February 3rd. HC Wainwright analyst P. Trucchio forecasts that the company will earn $1.10 per share for the yea
Oncolytics Biotech Inc. stock logo
HC Wainwright Reaffirms Buy Rating for Oncolytics Biotech (NASDAQ:ONCY)
HC Wainwright reiterated a "buy" rating and issued a $5.00 price target on shares of Oncolytics Biotech in a research note on Monday.
Oncolytics Biotech Inc. stock logo
Oncolytics Biotech (NASDAQ:ONCY) Stock Price Up 3.2% - Still a Buy?
Oncolytics Biotech (NASDAQ:ONCY) Shares Up 3.2% - Still a Buy?
Oncolytics Biotech Inc. stock logo
Oncolytics Biotech (NASDAQ:ONCY) Shares Down 2.1% - Here's What Happened
Oncolytics Biotech (NASDAQ:ONCY) Trading Down 2.1% - Should You Sell?
Oncolytics Biotech Inc. (ONC.TO)
Oncolytics Biotech Inc. stock logo
HC Wainwright Issues Pessimistic Estimate for ONCY Earnings
Oncolytics Biotech Inc. (NASDAQ:ONCY - Free Report) - Stock analysts at HC Wainwright cut their FY2024 earnings per share estimates for shares of Oncolytics Biotech in a research report issued to clients and investors on Wednesday, November 13th. HC Wainwright analyst P. Trucchio now expects that
Oncolytics Biotech Inc. stock logo
Oncolytics Biotech (NASDAQ:ONCY) Stock Rating Upgraded by Raymond James
Raymond James upgraded shares of Oncolytics Biotech to a "moderate buy" rating in a research note on Thursday.
Oncolytics Biotech Inc. stock logo
Oncolytics Biotech (NASDAQ:ONCY) Stock Rating Lowered by Leede Financial
Leede Financial lowered shares of Oncolytics Biotech from a "strong-buy" rating to a "moderate buy" rating in a report on Wednesday.
Oncolytics Biotech Inc. stock logo
What is Raymond James' Estimate for ONCY FY2024 Earnings?
Oncolytics Biotech Inc. (NASDAQ:ONCY - Free Report) - Stock analysts at Raymond James dropped their FY2024 earnings per share estimates for Oncolytics Biotech in a research report issued to clients and investors on Tuesday, November 12th. Raymond James analyst R. Sarugaser now expects that the co
Oncolytics Biotech Inc. stock logo
Oncolytics Biotech's (ONCY) "Buy" Rating Reaffirmed at HC Wainwright
HC Wainwright restated a "buy" rating and set a $5.00 price target on shares of Oncolytics Biotech in a report on Thursday.
Remove Ads
Get Oncolytics Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCY and its competitors with MarketBeat's FREE daily newsletter.

ONCY Media Mentions By Week

ONCY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ONCY
News Sentiment

1.89

0.81

Average
Medical
News Sentiment

ONCY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ONCY Articles
This Week

1

2

ONCY Articles
Average Week

Remove Ads
Get Oncolytics Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ONCY) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners